Page last updated: 2024-09-03

2'-deoxy-3',5'-di-o-acetyl-5-fluoro-3-(3-methylbenzoyl)uridine and Cancer of Intestines

2'-deoxy-3',5'-di-o-acetyl-5-fluoro-3-(3-methylbenzoyl)uridine has been researched along with Cancer of Intestines in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, K; Nagatomi, H; Takeshita, S1

Other Studies

1 other study(ies) available for 2'-deoxy-3',5'-di-o-acetyl-5-fluoro-3-(3-methylbenzoyl)uridine and Cancer of Intestines

ArticleYear
Alleviation of intestinal lesions by combined treatment with a 5-fluoro-2'-deoxyuridine (FUDR) derivative and alpha-difluoromethylornithine (DFMO)[correction of DMFO] in tumor-bearing mice.
    Biochemical pharmacology, 1992, Mar-17, Volume: 43, Issue:6

    Topics: Amine Oxidase (Copper-Containing); Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Eflornithine; Erythrocyte Count; Floxuridine; Intestinal Neoplasms; Male; Mice; Mice, Inbred ICR; Sarcoma, Experimental

1992